These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9576639)

  • 21. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A; Gentsch C
    Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.
    Enz A; Amstutz R; Boddeke H; Gmelin G; Malanowski J
    Prog Brain Res; 1993; 98():431-8. PubMed ID: 8248533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.
    Farlow MR; Hake A; Messina J; Hartman R; Veach J; Anand R
    Arch Neurol; 2001 Mar; 58(3):417-22. PubMed ID: 11255445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholinesterase inhibitor SDZ ENA 713 (Rivastigmine) increases brain pyrrolidone carboxyl peptidase activity.
    Ramírez-Expósito MJ; Robert-Baudouy J; Mayas MD; García MJ; Ramírez M; Martínez-Martos JM
    Eur Neuropsychopharmacol; 2001 Oct; 11(5):381-3. PubMed ID: 11597825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.
    Ballard CG
    Eur Neurol; 2002; 47(1):64-70. PubMed ID: 11803198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurophysiological predictors of long term response to AChE inhibitors in AD patients.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Ghirlanda S; Ranieri F; Gainotti G; Tonali P
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1064-9. PubMed ID: 16024879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors.
    Weinstock M; Razin M; Chorev M; Enz A
    J Neural Transm Suppl; 1994; 43():219-25. PubMed ID: 7884403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
    Articus K; Baier M; Tracik F; Kühn F; Preuss UW; Kurz A
    Int J Clin Pract; 2011 Jul; 65(7):790-6. PubMed ID: 21645184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R
    Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
    Bullock R
    Int J Clin Pract; 2002 Apr; 56(3):206-14. PubMed ID: 12018828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
    Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
    Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients.
    Stefanova E; Blennow K; Almkvist O; Hellström-Lindahl E; Nordberg A
    Neurosci Lett; 2003 Feb; 338(2):159-63. PubMed ID: 12566177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
    Xiao S; Wang T; Ma X; Qin Y; Li X; Zhao Z; Liu X; Wang X; Xie H; Jiang Q; Sun L; Luo B; Shang L; Chen W; Bai Y; Tang M; He M; Wu L; Ma Q; Hou D; He J
    Age Ageing; 2017 Sep; 46(5):767-773. PubMed ID: 28419192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic administration of acetylcholinesterase inhibitor in the senescent rat brain.
    Tanaka K; Ogawa N; Asanuma M; Kondo Y; Mori A
    Neurobiol Aging; 1994; 15(6):721-5. PubMed ID: 7891827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical treatment of Alzheimer's disease: past, present, and future.
    Ott BR
    Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
    Darreh-Shori T; Jelic V
    Expert Opin Drug Saf; 2010 Jan; 9(1):167-76. PubMed ID: 20021294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease.
    Jhee SS; Fabbri L; Piccinno A; Monici P; Moran S; Zarotsky V; Tan EY; Frackiewicz EJ; Shiovitz T
    Clin Neuropharmacol; 2003; 26(3):164-9. PubMed ID: 12782920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
    Jann MW; Shirley KL; Small GW
    Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.